About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
GRACE
cancergrace.org
Basic Science
Podcast Series
Targeted Therapies in Lung Cancer 2023
ASCO® 2023
Lung Cancer OncTalk
Blood Cancer OncTalk
2022 Melanoma Video Library
OncTalk 2022
ASCO Lung Review 2022
ASCO and ESMO Lung Recap
2021 Targeted Therapies Patient Forum
COVID-19
Lung
Hematologic Oncology
Head and Neck
Brain
Palliative
Genitourinary
General
Breast
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
K
PARP Inhibitors in Prostate Cancer Treatment
By
GRACE
FEATURING
Karan Jatwani
,
Karine Tawagi
,
Matthew Kurian
By
GRACE
FEATURING
Karan Jatwani
,
Karine Tawagi
,
Matthew Kurian
86 views
August 2, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
16:51
Incyte
Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk
Feat.
C. Harrison
Featured Video
16:26
Incyte
Effects of a Treatment Option on Hematocrit Control and Spleen Volum…
Feat.
C. Harrison
Genitourinary
06:46
GRACE
Anal Cancer Staging and Treatment Options
Feat.
P. Romesser
06:37
GRACE
Anal Cancer: Risk Factors and Prevention
Feat.
P. Romesser
04:48
GRACE
PARP Inhibitors in Prostate Cancer Treatment
Feat.
K. Jatwani,
K. Tawagi,
M. Kurian
03:48
GRACE
Cancer Genetics 101: Standard vs. Liquid Biopsy
Feat.
M. Kurian,
J. Adashek
05:27
GRACE
Understanding PSMA PET Scans in Prostate Cancer Diagnosis
Feat.
K. Jatwani,
K. Tawagi,
M. Kurian
06:15
GRACE
Chemotherapy Options for Prostate Cancer
Feat.
K. Jatwani,
K. Tawagi,
M. Kurian
08:21
GRACE
Medications for Advanced Stage Prostate Cancer Treatment
Feat.
K. Jatwani,
K. Tawagi,
M. Kurian
14:25
GRACE
The Role of ctDNA Biomarker in Bladder Cancer
Feat.
J. Brown
01:41
GRACE
Immunotherapy Side Effects in Bladder Cancer
Feat.
J. Brown
03:29
GRACE
Early vs. Advanced Stage Bladder Cancer Systemic Therapy
Feat.
J. Brown
02:39
GRACE
Cisplatin-Based Chemotherapy Regimens for Bladder Cancer
Feat.
J. Brown
04:18
GRACE
Cisplatin-Ineligible Treatment Options for Advanced Bladder Cancer
Feat.
J. Brown
02:36
GRACE
Avelumab Immunotherapy for Bladder Cancer
Feat.
J. Brown
02:11
GRACE
Future Trends for Bladder Cancer Treatment
Feat.
J. Brown
08:53
GRACE
Adjuvant Immunotherapy for Bladder Cancer: The IMvigor Trials
Feat.
P. Grivas
06:49
GRACE
PD-L1 in Metastatic Bladder Cancer
Feat.
J. Brown
15:59
GRACE
2020 Updates on MIBC: Bladder Preservation vs. Radical Cystectomy. W…
Feat.
P. Grivas,
R. Sedhom
08:49
GRACE
2020 Highlights on MIBC: What Are the Most Common Risks for Older Ad…
Feat.
E. Kessler,
R. Sedhom
14:38
GRACE
The Role of IO in Bladder Cancer: Potential Benefits in Neoadjuvant …
Feat.
E. Plimack,
R. Sedhom
17:29
GRACE
Androgen Deprivation Therapy (ADT) in Prostate Cancer: Side Effects …
Feat.
R. Sedhom,
T. Stewart
